These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 22096932)

  • 1. [Present management on HCV infected hemodialyzed patients].
    Zeniya M
    Nihon Rinsho; 2011 May; 69 Suppl 4():282-9. PubMed ID: 22096932
    [No Abstract]   [Full Text] [Related]  

  • 2. Pilot study on the safety and efficacy of intravenous natural beta-interferon therapy in patients with chronic hepatitis C unresponsive to alpha-interferon.
    Mazzoran L; Grassi G; Giacca M; Gerini U; Baracetti S; Fanni-Canelles M; Zorat F; Pozzato G
    Ital J Gastroenterol Hepatol; 1997 Aug; 29(4):338-42. PubMed ID: 9476188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis C in dialysed patients--what is the current optimal treatment?
    Kes P; Basic-Jukic N
    Kidney Blood Press Res; 2007; 30(3):156-61. PubMed ID: 17446715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon treatment of HCV positive cirrhotic patients.
    Idilman R; Colantoni A; De Maria N; Van Thiel DH
    Hepatogastroenterology; 1998; 45(20):340-4. PubMed ID: 9638403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon treatment for patients with chronic hepatitis C infected with high viral load of genotype 2 virus.
    Nakamura H; Ogawa H; Kuroda T; Yamamoto M; Enomoto H; Kishima Y; Yoshida K; Ito H; Matsuda M; Noguchi S
    Hepatogastroenterology; 2002; 49(47):1373-6. PubMed ID: 12239945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between chronic hepatitis C infection and coronary flow reserve in dialysis patients with failed renal allografts.
    Yelken B; Gorgulu N; Caliskan Y; Elitok A; Cimen AO; Yazici H; Oflaz H; Turkmen A; Sever MS
    Transplant Proc; 2009 Jun; 41(5):1519-23. PubMed ID: 19545669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hepatitis C in hemodialysis patients].
    Miyano M; Tanaka H; Ishitani S
    Nihon Rinsho; 2001 Jul; 59(7):1289-93. PubMed ID: 11494539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Natural history, diagnosis and treatment of chronic hepatitis B and C in hemodialysis patients].
    Nicolardi E; Grieco A; Rapaccini GL; Pompili M
    G Ital Nefrol; 2010; 27(3):262-73. PubMed ID: 20540019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Epidemiology of chronic hepatitis B and C among dialysis patients in Switzerland].
    Ambühl PM; Binswanger U; Renner EL
    Schweiz Med Wochenschr; 2000 Mar; 130(10):341-8. PubMed ID: 10763211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Occult hepatitis B virus infection in hemodialysis patients with chronic HCV infection.
    Siagris D; Christofidou M; Triga K; Pagoni N; Theocharis GJ; Goumenos D; Lekkou A; Thomopoulos K; Tsamandas AC; Vlachojannis J; Labropoulou-Karatza C
    J Nephrol; 2006; 19(3):327-33. PubMed ID: 16874693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatocyte steatosis is an important predictor of response to interferon (IFN) monotherapy in Japanese patients infected with HCV genotype 2a: Virological features of IFN-resistant cases with hepatocyte steatosis.
    Akuta N; Suzuki F; Suzuki Y; Sezaki H; Hosaka T; Someya T; Kobayashi M; Saitoh S; Arase Y; Ikeda K; Kobayashi M; Kumada H
    J Med Virol; 2005 Apr; 75(4):550-8. PubMed ID: 15714492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of mixed hepatitis C virus (HCV) genotypes among recently diagnosed dialysis patients with HCV infection.
    Al Balwi MA
    Saudi J Kidney Dis Transpl; 2011 Jul; 22(4):712-6. PubMed ID: 21743215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [beta-Interferon therapy of chronic hepatitis HCV+, 1b genotype].
    Vezzoli M; Girola S; Fossati G; Mazzucchelli I; Gritti D; Mazzone A
    Recenti Prog Med; 1998 May; 89(5):235-40. PubMed ID: 9676129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon monotherapy for dialysis patients with chronic hepatitis C: an analysis of the literature on efficacy and safety.
    Russo MW; Goldsweig CD; Jacobson IM; Brown RS
    Am J Gastroenterol; 2003 Jul; 98(7):1610-5. PubMed ID: 12873587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of hepatitis C virus infection in patients with end-stage renal disease.
    Liu CH; Kao JH
    J Gastroenterol Hepatol; 2011 Feb; 26(2):228-39. PubMed ID: 21261711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An urgency to identify and treat chronic hepatitis C.
    Pockros PJ
    Minerva Gastroenterol Dietol; 2005 Sep; 51(3):235-46. PubMed ID: 16280965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hepatitis C virus infection in renal-transplant patients].
    Kamar N; Izopet J; Ribes D; Rostaing L
    Nephrologie; 2004; 25(1):9-15. PubMed ID: 15022868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Chronic hepatitis B and C in HIV-infected patients].
    Opravil M; Hunziker R; Lüthy R; Grob PJ
    Dtsch Med Wochenschr; 1998 Jun; 123(24):753-60. PubMed ID: 9672477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The kidney transplant recipient with hepatitis C infection: pre- and posttransplantation treatment.
    Terrault NA; Adey DB
    Clin J Am Soc Nephrol; 2007 May; 2(3):563-75. PubMed ID: 17699464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of the efficacy of intravenous natural interferon-beta treatment in chronic hepatitis C.
    Fukutomi T; Fukutomi M; Iwao M; Watanabe H; Tanabe Y; Hiroshige K; Kinukawa N; Nakamuta M; Nawata H
    Med Sci Monit; 2000; 6(4):692-8. PubMed ID: 11208393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.